The aim of VPHOP is to develop a multiscale modelling technology based on conventional diagnostic imaging methods that makes it possible, in a clinical setting, to predict for each patient the strength of his/her bones, how this strength is likely to change over time, and the probability that the he/she will overload his/her bones during daily life. With these three predictions, the evaluation of the absolute risk of bone fracture will be much more accurate than any prediction based on external and indirect determinants, as it is current clinical practice.
These predictions will be used to:
- improve the diagnostic accuracy of the current clinical standards;
- to provide the basis for an evidence-based prognosis with respect to the natural evolution of the disease, to pharmacological treatments, and/or to preventive interventional treatments aimed to selectively strengthen particularly weak regions of the skeleton.
For patients at high risk of fracture, and for which the pharmacological treatment appears insufficient, the VPHOP system will also assist the interventional radiologist in planning the augmentation procedure. The various modelling technologies developed during the project will be validated not only in vitro, on animal models, or against retrospective clinical outcomes, but will also be assessed in term of clinical impact and safety on small cohorts of patients enrolled at four different clinical institutions, providing the factual basis for effective clinical and industrial exploitations.
For further information, please visit:
Istituto Ortopedico Rizzoli
- SCS SRL
- Société dEtudes et de Recherches de lEcole Nationale Supérieure dArts et Métiers
- Universität Bern
- Biospace Med SA
- University of Bedfordshire
- Technische Universiteit Eindhoven
- Philips Medical Systems Nederland BV
- empirica Gesellschaft für Kommunikations- und Technologieforschung mbH
- Université de Genève (UNIGE)
- Sylvia Lawry Centre for Multiple Sclerosis Research e.V.
- ANSYS France SAS
- Háskóli Íslands
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Uppsala universitet
- Charité - Universitätsmedizin Berlin
- Eidgenössische Technische Hochschule Zürich (ETHZ)
- BrainLAB AG
- Katholieke Universiteit Leuven
Timetable: from 08/2008 to 08/2012
Total cost: 12.073.349
EC funding: 8.989.363
Programme Acronym: FP7-ICT
Subprogramme Area: Virtual physiological human
Contract type: Collaborative project (generic)
Related news articles::